S&P 500 Giant Leads 5 Stocks Near Buy Points
Earnings season is in full swing, and a number of stocks are making strong moves as quarterly results roll in. Financial giant JPMorgan Chase (JPM) is testing a buy point near record highs after clearing estimates last week.
AI-related play Amphenol (APH) is also hovering near an entry, along with alloy maker Carpenter Technology (CRS). ResMed broke out following its Thursday night results. On Holding rallied Friday on the back of a strong beat from competitor Deckers Outdoor (DECK).
↑
X
S&P 500 Giants Report Earnings. Will Megacap Results Sustain The Tech Rally?
On Holding
Hoka maker Deckers Outdoor (DECK) led a sprint for footwear stocks on Friday after a strong Q2 2025 beat.
Rival On Holding (ONON) leapt 6.45% after the report, rebounding decisively above its 50-day moving average and break a short downtrend.
SwingTrader added ONON shares with a 3/4 position on Friday at a 50.65 entry.
On hasn’t released a date for its Q3 results yet. But FactSet analysts expect flat earnings per share vs. a year earlier on nearly 32% revenue growth to $711 million.
ONON stock has rallied 88% so far this year. Shares are approaching their record high of 55.87 from November 2021.
Amphenol
Amphenol, a manufacturer of cables, sensors, circuits and connectors for data centers, delivered a record beat-and-raise Q3 report on Wednesday and noted a boost in sales from an increase in artificial intelligence applications.
Baird in a research note on Thursday said Amphenol’s AI and non-AI applications drove excellent IT data-communications growth. But the company’s AI-related strength is really driving accelerating business momentum.
Amphenol earnings and revenue growth accelerated over the last four quarters, to a 28% gain and a 26% increase, respectively.
APH stock is hovering below a 70.48 buy point for a 17-week consolidation. Shares tested the entry on Wednesday before easing.
Amphenol stock rose 2.9% to 69.42 for the week. is up 40% this year and trading around record highs.
ResMed
CPAP producer ResMed broke out on its Q3 earnings Friday, shrugging off concerns that popular weight-loss drugs would hamper demand for its sleep apnea machines.
Adjusted earnings increased 34% to $2.20 per share, clearing expectations for $2.05 per share. Sales rose 11% to $1.22 billion to beat estimates for $1.19 billion.
The results marked four consecutive quarters of accelerating earnings growth.
RMD stock spiked 7.1 Friday to bound above its 50-day line and just clear a 255.18 flat base buy point.
The current buy zone, which stretches 5% beyond the buy point, extends to 267.93.
ResMed stock is up 49% this year.
JPMorgan Chase
JPM stock is trading right below a 225.48 buy point for a cup base — also its record high — after JPMorgan Chase cleared Q3 estimates on Oct. 11.
The Dow Jones bank reported earnings of $4.37 per share on $42.7 billion in revenue, while FactSet expected $3.99 per share on $41.43 billion.
The S&P 500 giant tested the buy point a few times since earnings but hasn’t been able to score a decisive breakout.
JPM stock dipped below its 10-day line on Friday but is holding above its other key moving averages.
JPMorgan has advanced more than 30% in 2024.
Carpenter Technology
Carpenter Technology on Wednesday topped Q2 2025 earnings estimates and CEO Tony Thene said it was the most profitable first quarter in company history. Adjusted earnings for the Philadelphia-based alloy maker nearly doubled to $1.73 per share, outpacing FactSet expectations for $1.58 per share. However, revenue only rose 10% to $718 million, while analysts expected $743 million.
Carpenter said it expects 2025 operating income to be at the high end of its previous guidance for $460 million to $500 million, but that was short of analyst estimates for $502 million.
The company guided Q2 operating income between $116 and $123 million, with the midpoint above analyst forecasts for $117 million.
CRS stock briefly undercut its 50-day line and a 148.98 buy point Thursday after its sales and guidance miss, but pared losses significantly. Carpenter edged higher on Friday, just below its 21-day line. The stock is technically back in a buy zone for its Sept. 18 breakout.
But investors perhaps should focus on an emerging consolidation, which could turn into a flat base after another week. Use Wednesday’s high of 161.70 as an early entry.
Carpenter Technology shares rocketed more than 119% this year and hit an all-time high of 166.51 on Sept. 26.
You can follow Harrison Miller for more stock news and updates on X/Twitter @IBD_Harrison
YOU MAY ALSO LIKE:
Best Growth Stocks To Buy And Watch: See Updates To IBD Stock Lists
Looking For The Next Big Stock Market Winners? Start With These 3 Steps
Join IBD Live And Learn Top Chart Reading And Trading Techniques From Pros
Learn How To Time The Market With IBD’s ETF Market Strategy
The Nasdaq Is At Highs. These 5 Earnings Could Change Everything.
AI Demand Fuels Record Profits, Chip Controversies, And Tech Giants Redefine AI Landscape: This Week In The World Of Artificial Intelligence
The week was buzzing with significant developments in the tech world, with artificial intelligence (AI) at the center of it all. From record-breaking profits driven by AI demand to potential violations of export rules, the tech industry kept us on our toes. Here’s a quick roundup of the top stories that shaped the weekend.
Nvidia Supplier SK Hynix Hits Record Profits
SK Hynix HXSCF, a key supplier to Nvidia Corp. NVDA, reported a record-breaking quarterly profit, fueled by the rising demand for artificial intelligence technology. The South Korean semiconductor company posted a 7% revenue increase from the previous quarter, marking its highest-ever quarterly revenue.
TSMC’s Chip Found in Huawei’s AI Product
Taiwan Semiconductor Manufacturing Company TSM alerted the U.S. Commerce Department after a tech research firm discovered one of its chips in a Huawei product. The product in question is Huawei’s Ascend 910B, considered the most advanced AI chip from a Chinese company.
Chinese AI Firms Defy US Chip Sanctions
Despite U.S. chip sanctions, Chinese AI firms, including Alibaba Group Holding Ltd. BABA and ByteDance Ltd., are making strides in reducing AI costs. These companies are focusing on smaller data sets, hiring cheaper engineering talent, and optimizing hardware.
Apple Intelligence Set to Revolutionize Products
Apple Inc.’s AAPL CEO Tim Cook has high expectations for Apple Intelligence, believing it will make their products ‘profoundly different’. Cook anticipates that the release of Apple Intelligence will be one of the biggest technology releases in Apple’s history.
Nvidia’s New AI Model Outperforms Competitors
Nvidia Corp. introduced a new AI model, Llama-3.1-Nemotron-70B-Instruct, that has reportedly outperformed its competitors in benchmark tests. The model, built on Meta Platforms Inc.’s META Llama 3.1 framework, has shown remarkable efficiency and performance.
Read Next:
Photo courtesy: Shutterstock
This story was generated using Benzinga Neuro and edited by Rounak Jain
Market News and Data brought to you by Benzinga APIs
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
'Housing Affordability Was The Exception': Renters And Homeowners Differ On Key Election Issue, Redfin Says
Housing affordability is a dividing line between renters and homeowners before the presidential election. According to new data from Redfin, renters are twice as likely to prioritize the issue when choosing a candidate.
A September 2024 survey conducted by Ipsos for the real estate company shows that 31.6% of U.S. renters rank housing affordability among their top three election issues, while just 17.1% of homeowners share the same concern.
Don’t Miss:
The broader economic landscape dominates voter priorities, with 46% of all respondents listing the economy as a top-three issue, followed by inflation at 40.4% and health care at 26.3%.
The housing concern split reflects the diverging financial trajectories of owners and renters over the past four years. Most homeowners (52.1%) report improved financial standing compared to 2020, while only 44.2% of renters say the same.
According to the report, record-low mortgage rates during the pandemic enabled many Americans to become homeowners. However, others were unable to buy homes due to the surge in housing prices caused by increased demand.
Trending: Warren Buffett once said, “If you don’t find a way to make money while you sleep, you will work until you die.” These high-yield real estate notes that pay 7.5% – 9% make earning passive income easier than ever.
The survey also revealed a political dimension to housing concerns. About 25.1% of Harris supporters rank housing affordability as a top issue compared to 20.4% of Trump supporters. Redfin Chief Economist Daryl Fairweather attributes the gap to demographics, noting that Democrats typically concentrate in expensive coastal areas.
Among renters specifically, Harris holds an edge on housing policy. A separate Redfin survey found 48.4% of renters believe she would better address affordability concerns, versus 31.2% for Trump. This translates to broader support, with 43.6% of renters planning to vote for Harris compared to 28% for Trump.
See Also: This Jeff Bezos-backed startup will allow you to become a landlord in just 10 minutes, and you only need $100.
Both candidates have outlined plans to address the housing crisis. Harris proposes building three million new homes over four years and offering $25,000 in down-payment assistance to first-time buyers. Trump links housing affordability to immigration policy, arguing that reducing immigration would ease housing demand.
However, housing experts warn against oversimplifying the issue. Jenny Schuetz, senior fellow at Brookings Metro, told the Los Angeles Times that federal influence over housing construction is limited, suggesting the challenge requires coordinated efforts across multiple levels of government.
The Ipsos survey, which gathered responses from 894 renters and 805 homeowners aged 18-65, points to how housing costs increasingly shape political preferences, particularly among renters facing persistent affordability challenges.
According to the report, while renters and homeowners share similar views on most issues, “housing affordability was the exception.”
Read Next:
Market News and Data brought to you by Benzinga APIs
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
3 Superb Dividend King Stocks for Buy-and-Hold Investors
Coca-Cola (NYSE: KO), PepsiCo (NASDAQ: PEP), and Procter & Gamble (NYSE: PG) are three well-known consumer-facing companies. They are also Dividend Kings, meaning they have paid and raised their dividends for at least 50 consecutive years.
All three companies reported earnings within the last month. In those reports and earnings calls, they discussed a similar challenge that has been affecting their sales.
Here’s what you need to know about the state of each business and what makes all three companies excellent dividend stocks to buy and hold now.
Coca-Cola and PepsiCo have various nonalcoholic beverage brands. PepsiCo is more diversified than Coke since it owns Frito-Lay and Quaker Oats and isn’t solely focused on beverages. Meanwhile, P&G owns dozens of brands in the beauty, grooming, healthcare, fabric and home care, and other categories.
All three companies have global operations and heavily depend on international sales to drive growth. The global footprint is great for tapping into emerging markets and achieving diversification. But now, weak demand (especially in China) and unfavorable currency conversion rates have affected margins.
The biggest challenge for all three companies has been a decline in sales volumes. Sometimes, volume declines for one business can be a sign that it lacks pricing power or is losing market share to the competition. But when it is a widespread problem, like we see today, it usually means that consumer spending is in a cyclical downturn.
For the nine months ended Sept. 27, Coca-Cola reported just a 1% increase in unit case volume. In PepsiCo’s third-quarter report, it posted a 2% year-to-date decline in convenience-foods volume and a 1% decrease in beverages volume.
In P&G’s recent quarter, which was first-quarter fiscal year 2025, the company reported flat overall volume and a 1% increase in organic volumes. For P&G’s fiscal year, ended June 30, it reported flat overall volumes, including volume declines in two key segments: baby, feminine & family care and healthcare.
Despite weak volumes for Coca-Cola, PepsiCo, and P&G, all three companies are still growing overall sales and earnings thanks to efficiency improvements, cost management, and pricing power. But prices can only be raised so much before consumers push back.
PepsiCo, in particular, is feeling the effects of taking price increases too far. As mentioned, it is seeing the worst volume declines. So to drum up demand, it has decided not to cut prices, but instead to include more product in packages on a case-by-case basis, such as adding 20% more product in Tostitos and Ruffles bags and bonus bags in variety packs.
WGO INVESTOR NEWS: Winnebago Industries, Inc. Investors that Suffered Losses Are Encouraged to Contact Rosen Law About Ongoing Investigation into the Company (NYSE: WGO)
NEW YORK, Oct. 27, 2024 (GLOBE NEWSWIRE) — Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Winnebago Industries, Inc. WGO resulting from allegations that Winnebago may have issued materially misleading business information to the investing public.
If you invested in Winnebago securities, you are encouraged to obtain additional information by visiting https://rosenlegal.com/case/winnebago-industries-inc/.
Why Did Winnebago Industries’ Stock Drop?
On September 23, 2024, during market hours, Hunterbrook Media published an article called “‘Grand Deception’- Winnebago Muzzles Outcry Over Major Problem That Owners Say Makes RVs Dangerous, Untowable, Worthless.” In this article, Hunterbrook said Winnebago’s “best-selling Grand Design RVs” appear to be “experiencing frame failure, potentially affecting thousands of units sold for more than a billion dollars. This defect has led to costly damage and potential safety hazards, and rendered some RVs unroadworthy.” Further, the article stated “Winnebago has used NDAs, buybacks, and online censorship to silence complaints about frame failure[.]”
On this news, Winnebago’s stock fell $1.35 per share, or 2.28%, to close at $57.76 per share on September 23, 2024.
Click here for more information: https://rosenlegal.com/case/winnebago-industries-inc/.
What Can You Do?
If you invested in Winnebago Industries, you may have legal options and are encouraged to submit your information to the firm. All representation is on a contingency fee basis, there is no cost to you. Shareholders are not responsible for any court costs or expenses of litigation. The firm will seek court approval for any potential fees and expenses.
Submit your information by visiting: https://rosenlegal.com/submit-form/?case_id=29071.
Why Rosen Law Firm?
We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers.
For more information about Rosen Law and its attorneys, please visit https://rosenlegal.com/.
Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.
Attorney Advertising. Prior results do not guarantee a similar outcome.
Contact Information:
Laurence Rosen, Esq.
Phillip Kim, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 40th Floor
New York, NY 10016
Tel: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827
case@rosenlegal.com
www.rosenlegal.com
Market News and Data brought to you by Benzinga APIs
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
How Much International Travel Health Insurance Do I Need?
SmartAsset and Yahoo Finance LLC may earn commission or revenue through links in the content below.
International travel health insurance provides coverage for medical expenses incurred while traveling abroad. Policies can help pay for unexpected situations such as accidents, illnesses or emergency medical evacuations. The amount of coverage needed may vary depending on the destination, length of stay and planned activities. Some countries require travelers to carry health insurance as part of their entry requirements, while others may have high medical costs, making insurance a practical safety net. Travelers should also consider whether their domestic health insurance covers any medical care overseas, as many plans offer little to no international coverage.
A financial advisor can help assess how much insurance you need and recommend coverage that aligns with your financial goals and risk tolerance.
International travel health insurance is designed to cover healthcare expenses that may arise while a person is traveling outside their home country. It offers financial protection for medical emergencies, such as unexpected illnesses, injuries or the need for hospitalization. In some cases, these policies also cover emergency medical evacuation, ensuring travelers can be transported to a qualified medical facility or even back home if necessary.
Coverage can vary, but typical policies include doctor visits, prescription medication, hospital stays and urgent dental care. Some plans extend beyond emergency situations to include benefits like trip interruption due to a medical issue or coverage for pre-existing conditions, though these may require specific add-ons. Travel health insurance is different from standard travel insurance, which focuses more on trip cancellations and lost baggage.
Premiums for international travel health insurance are generally affordable. Many plans charge less than $50 for coverage. More costly plans with extra features may require premiums of more than $100.
Given that healthcare systems and costs differ significantly across countries, having this coverage can help travelers avoid high out-of-pocket expenses. It’s also useful for peace of mind, especially when traveling to remote locations or places with limited medical infrastructure.
International travel health insurance can be purchased through insurance providers, travel agencies or comparison websites that specialize in travel coverage. Start by evaluating your needs, including the destination, trip length and any planned activities that may pose health risks. Many providers offer single-trip, multi-trip or long-term plans, so choosing the right policy depends on how often and how far you travel.
EVLV FRAUD ALERT: BFA Law Notifies Evolv Technologies Investors of Ongoing Securities Fraud Investigation for Accounting Errors and Urges You to Contact the Firm (Nasdaq: EVLV)
NEW YORK, Oct. 27, 2024 (GLOBE NEWSWIRE) — Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Evolv Technologies Holdings, Inc. EVLV for potential violations of the federal securities laws.
If you invested in Evolv Technologies, you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/evolv-technologies-holdings-inc.
Why Did Evolv Technologies’s Stock Drop?
On October 25, 2024, Evolv announced a delay in filing its upcoming quarterly financial report due to an internal investigation revealing material misstatements in revenue recognition dating back to 2022. Evolv also announced that certain financial statements from 2022 to mid-2024 should not be relied upon, as sales to channel partners, including one of Evolv’s largest channel partners, involved undisclosed terms impacting reported revenue.
The news has caused a precipitous decline in the price of Evolv stock. During trading on October 25, 2024, the price of Evolv stock declined more than 40%.
Click here for more information: https://www.bfalaw.com/cases-investigations/evolv-technologies-holdings-inc.
What Can You Do?
If you invested in Evolv Technologies you may have legal options and are encouraged to submit your information to the firm.
All representation is on a contingency fee basis, there is no cost to you. Shareholders are not responsible for any court costs or expenses of litigation. The firm will seek court approval for any potential fees and expenses.
Submit your information by visiting:
https://www.bfalaw.com/cases-investigations/evolv-technologies-holdings-inc
Or contact:
Ross Shikowitz
ross@bfalaw.com
212-789-3619
Why Bleichmar Fonti & Auld LLP?
Bleichmar Fonti & Auld LLP is a leading international law firm representing plaintiffs in securities class actions and shareholder litigation. It was named among the Top 5 plaintiff law firms by ISS SCAS in 2023 and its attorneys have been named Titans of the Plaintiffs’ Bar by Law360 and SuperLawyers by Thompson Reuters. Among its recent notable successes, BFA recovered over $900 million in value from Tesla, Inc.’s Board of Directors (pending court approval), as well as $420 million from Teva Pharmaceutical Ind. Ltd.
For more information about BFA and its attorneys, please visit https://www.bfalaw.com.
https://www.bfalaw.com/cases-investigations/evolv-technologies-holdings-inc
Attorney advertising. Past results do not guarantee future outcomes.
Market News and Data brought to you by Benzinga APIs
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Why Is Gold Mining Dividend Stock Newmont Selling Off With Gold Prices at All-Time Highs?
Shares of gold miner Newmont (NYSE: NEM) fell 14.7% on Thursday after the company reported third-quarter 2024 results. The sell-off may seem strange, given gold prices are still hovering around an all-time high.
Here’s what’s driving the sell-off in the dividend stock and why there may be better options for investing in gold than mining stocks.
2024 has been a phenomenal year for gold stocks and most mining stocks. In fact, until the recent sell-off, shares of Newmont and the price of gold were both outperforming the S&P 500 index (SNPINDEX: ^GSPC) year to date — which is impressive considering it has been an excellent year for the broader market. Even after the recent pullback, Newmont stock is still up 19% year to date.
The main issue is that expectations got ahead of reality. In the short term, it can be difficult for gold miners to keep pace with the price of gold because they have to spend more to produce more, and capital spending plans are usually made based on midcycle expectations rather than overextending at the top of a cycle.
Analysts expected Newmont to book $0.86 in adjusted earnings per share (EPS), but it only notched $0.81 in adjusted EPS. Still, Newmont’s results were incredibly impressive and included $760 million in free cash flow (FCF). However, third-quarter sales grew 4.6% quarter over quarter compared to a 7.1% increase in costs applicable to sales. Costs outpacing sales growth is never a good sign because it can lead to lower margins and worse-than-expected earnings growth.
Newmont bought back $500 million in stock during the quarter and returned $786 million to shareholders through stock repurchases and dividend payments — which was more than the FCF it earned for the quarter. Newmont’s dividend payment can vary based on the performance of the business, but it currently sits at $0.25 per share per quarter. Some investors may have preferred Newmont to pay a higher dividend than buy back stock. After all, Newmont’s average price paid per share was $53.16 — which is higher than the closing price of the stock after Thursday’s sell-off.
Still, the sell-off in Newmont is probably due more to the stock price getting ahead of itself than poor results. There’s a lot to like from Newmont’s results and its fourth-quarter guidance. As of Oct. 23, the stock was up over 50% in the past year compared to a 34.3% increase in the price of gold. Newmont had a huge surge in October before the recent sell-off. So, there was a lot of pressure on Newmont to deliver a perfect quarter, which it didn’t do.